Immune system replacement

Immune system replacement" is not the name of a specific molecule, receptor, or canonical therapeutic target. Instead, it refers broadly to medical interventions that restore or replace components of the immune system in patients with immunodeficiency or after treatments that ablate immunity (such as chemotherapy or stem cell transplantation). Common approaches include: - **Immunoglobulin (antibody) replacement therapy**, which provides pooled antibodies from donors to patients with antibody deficiencies[1][2][3][4][5][6]. - **Stem cell transplantation** (including bone marrow transplant), which replaces a patient's entire hematopoietic and immune system using donor cells[7]. - **CAR T-cell therapy** and other cellular therapies that can reconstitute aspects of adaptive immunity[10]. These are procedures or treatment strategies rather than discrete molecular targets. Therefore, "Immune system replacement" does not correspond to a single protein, gene product, receptor, enzyme, transporter, or other molecular entity typically considered a drug target. If you are seeking information on a specific molecule involved in these processes—such as "immunoglobulin," "CD19," "hematopoietic stem cell," etc.—please specify for more structured data. In summary: > The term “Immune system replacement” is too broad and non-specific for use as a canonical drug target; it describes clinical strategies rather than an individual molecular entity suitable for structured annotation as requested.

Other names

Immune system replacementimmune reconstitutionimmune replacement therapy (non-standard)